期刊
JOURNAL OF IMMUNOLOGY
卷 182, 期 9, 页码 5203-5207出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.0804243
关键词
-
类别
资金
- Wellcome trust [079115, 073055, 068590]
- Medical Research Council [G117/488] Funding Source: researchfish
- MRC [G117/488] Funding Source: UKRI
CD59, a broadly expressed GPI-anchored molecule, regulates formation of the membrane attack complex of the complement cascade. We previously demonstrated that mouse CD59 also down-modulates CD4(+) T cell activity in vivo. In this study, we explored the role of CD59 on human CD4(+) T cells. Our data demonstrate that CD59 is up-regulated on activated CD4(+) 1 : cells and serves to down-modulate their activity in response to polyclonal and Ag- specific stimulation. The therapeutic potential of this finding was explored using T cells isolated from colorectal cancer patients. The findings were striking and indicated that blockade of CD59 significantly enhanced the CD4(+) T cell response to two different tumor Ags. These data highlight the potential for manipulating CD59 expression on T cells for boosting weak immune responses, such as those found in individuals with cancer. The Journal of Immunology, 2009, 182: 5203-5207.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据